Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 5
1973 10
1974 18
1975 13
1976 18
1977 23
1978 20
1979 25
1980 26
1981 24
1982 25
1983 36
1984 43
1985 54
1986 48
1987 42
1988 44
1989 63
1990 62
1991 45
1992 29
1993 44
1994 18
1995 38
1996 35
1997 31
1998 26
1999 31
2000 48
2001 28
2002 35
2003 36
2004 28
2005 26
2006 37
2007 27
2008 35
2009 33
2010 40
2011 30
2012 39
2013 50
2014 40
2015 38
2016 43
2017 32
2018 26
2019 33
2020 31
2021 23
2022 31
2023 22
2024 29
2025 38
2026 33

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,727 results

Results by year

Filters applied: . Clear all
Page 1
The mechanistic role of piracetam in the management of vascular dementia.
Al-Kuraishy HM, Al-Gareeb AI, Eliwa D, Alexiou A, Papadakis M, Alruwaili M, Batiha GE. Al-Kuraishy HM, et al. Behav Brain Res. 2025 May 28;486:115551. doi: 10.1016/j.bbr.2025.115551. Epub 2025 Mar 24. Behav Brain Res. 2025. PMID: 40139397 Review.
Hence, piracetam has a neuroprotective effect against VaD. However, the exact neuroprotective mechanism of piracetam against the development and progression of VaD was not fully clarified. Consequently, this review attempts to discuss the potential effect of pira …
Hence, piracetam has a neuroprotective effect against VaD. However, the exact neuroprotective mechanism of piracetam against t …
Efficacy of piracetam in children with breath-holding spells: a systematic review and meta-analysis.
Sharawat IK, Dawman L, Panda P, Panda PK. Sharawat IK, et al. Eur J Pediatr. 2024 Dec 18;184(1):89. doi: 10.1007/s00431-024-05926-4. Eur J Pediatr. 2024. PMID: 39692893
Several studies have investigated the efficacy of piracetam in reducing the frequency and severity of BHS, with mixed results. What is new? Oral piracetam is efficacious and safe in children with BHS. Its efficacy is further increased by co-administration of ora …
Several studies have investigated the efficacy of piracetam in reducing the frequency and severity of BHS, with mixed results. What i …
The effectiveness of piracetam in vertigo.
Oosterveld WJ. Oosterveld WJ. Pharmacopsychiatry. 1999 Mar;32 Suppl 1:54-60. doi: 10.1055/s-2007-979238. Pharmacopsychiatry. 1999. PMID: 10338110 Review.
Piracetam decreases the frequency but probably not the severity of exacerbations in patients with chronic or recurrent vertigo. The usual dosage of piracetam in vertigo is 2.4-4.8 g daily. Tolerability of piracetam is good and adverse effects have been mild a …
Piracetam decreases the frequency but probably not the severity of exacerbations in patients with chronic or recurrent vertigo. The u …
Positive Experiences With Piracetam.
Beutner FU. Beutner FU. Dtsch Arztebl Int. 2020 Feb 14;116(7):116. doi: 10.3238/arztebl.2020.0116a. Dtsch Arztebl Int. 2020. PMID: 32164824 Free PMC article. No abstract available.
Piracetam for acute ischaemic stroke.
Ricci S, Celani MG, Cantisani AT, Righetti E. Ricci S, et al. Cochrane Database Syst Rev. 2000;(2):CD000419. doi: 10.1002/14651858.CD000419. Cochrane Database Syst Rev. 2000. PMID: 10796359
BACKGROUND: Piracetam has neuroprotective and antithrombotic effects which may help to reduce death and disability in people with acute stroke. ...Piracetam does not appear to reduce dependency for stroke patients....
BACKGROUND: Piracetam has neuroprotective and antithrombotic effects which may help to reduce death and disability in people with acu …
Piracetam for acute ischaemic stroke.
Ricci S, Celani MG, Cantisani AT, Righetti E. Ricci S, et al. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000419. doi: 10.1002/14651858.CD000419.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2012 Sep 12;(9):CD000419. doi: 10.1002/14651858.CD000419.pub3. PMID: 16625535 Updated.
We also contacted the manufacturer of piracetam to identify further published and unpublished studies. SELECTION CRITERIA: Randomised trials comparing piracetam with control, with at least mortality reported and entry to the trial within approximately 48 hours of st …
We also contacted the manufacturer of piracetam to identify further published and unpublished studies. SELECTION CRITERIA: Randomised …
Piracetam for acute ischaemic stroke.
Ricci S, Celani MG, Cantisani TA, Righetti E. Ricci S, et al. Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD000419. doi: 10.1002/14651858.CD000419.pub3. Cochrane Database Syst Rev. 2012. PMID: 22972044 Free PMC article.
We also contacted the manufacturer of piracetam to identify further published and unpublished studies. SELECTION CRITERIA: Randomised trials comparing piracetam with control, with at least mortality reported and entry to the trial within three days of stroke onset. …
We also contacted the manufacturer of piracetam to identify further published and unpublished studies. SELECTION CRITERIA: Randomised …
Piracetam for fetal distress in labour.
Hofmeyr GJ, Kulier R. Hofmeyr GJ, et al. Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD001064. doi: 10.1002/14651858.CD001064.pub2. Cochrane Database Syst Rev. 2012. PMID: 22696322 Free PMC article.
SELECTION CRITERIA: Randomised trials of piracetam compared with placebo or no treatment for suspected fetal distress in labour. ...AUTHORS' CONCLUSIONS: There is not enough evidence to evaluate the use of piracetam for fetal distress in labour....
SELECTION CRITERIA: Randomised trials of piracetam compared with placebo or no treatment for suspected fetal distress in labour. ...A …
Piracetam--an old drug with novel properties?
Winnicka K, Tomasiak M, Bielawska A. Winnicka K, et al. Acta Pol Pharm. 2005 Sep-Oct;62(5):405-9. Acta Pol Pharm. 2005. PMID: 16459490 Free article. Review.
Piracetam (2-oxo-1-pyrrolidine-acetamide), the most common of the nootropic drugs, is a cyclic derivative of gamma-aminobutyric acid. The treatment with piracetam improves learning, memory, brain metabolism, and capacity. Piracetam has been shown to alter the …
Piracetam (2-oxo-1-pyrrolidine-acetamide), the most common of the nootropic drugs, is a cyclic derivative of gamma-aminobutyric acid. …
Piracetam in the treatment of cortical myoclonus.
Genton P, Guerrini R, Remy C. Genton P, et al. Pharmacopsychiatry. 1999 Mar;32 Suppl 1:49-53. doi: 10.1055/s-2007-979237. Pharmacopsychiatry. 1999. PMID: 10338109 Review.
Tolerability after long-term use of piracetam in high dosage has been very good and without toxicity or serious adverse effects. ...Piracetam should be considered a first-line drug for the treatment of cortical myoclonus....
Tolerability after long-term use of piracetam in high dosage has been very good and without toxicity or serious adverse effects. ... …
1,727 results